An Eight-week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80mg Plus Amlodipine 5 mg Fixed-dose Combination vs. Telmisartan 40 mg Plus Amlodipine 5 mg Fixed-dose Combination in Patients With Hypertension.
Phase of Trial: Phase III
Latest Information Update: 13 Dec 2013
At a glance
- Drugs Amlodipine/telmisartan (Primary)
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 19 Oct 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 19 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.